For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

Prolynx LLC

USPTO Granted Patents = 20

EPO Patents = 6

Forward Citations = 140

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Gary W Ashley (16 out of 56 patents)

Daniel V Santi (15 out of 62 patents)

Jeffrey C Henise (5 out of 5 patents)

4. Eric L Schneider (5 out of 6 patents)

5. Brian R Hearn (4 out of 11 patents)

6. Shaun Fontaine (3 out of 3 patents)

7. Richard T W Wilson (1 out of 1 patent)

8. Jonathan J H G Oskam (1 out of 1 patent)

9. John A Hangasky, Iii (1 out of 1 patent)

10. Samuel J Pfaff (1 out of 1 patent)

11. Jeffrey C Henise (1 out of 1 patent)

12. Daniel V Santi (1 out of 1 patent)

20 patents: Sort by Forward Citations

1. 12697395 - SLOW-RELEASE CYTOKINE CONJUGATES (2026-08-04),

2. 12478680 - HYDROGELS WITH BIODEGRADABLE CROSSLINKING (2025-11-25),

3. 12472261 - Conjugated inhibitors of DNA damage response (2025-11-18),

4. 12364771 - Conjugation linkers (2025-07-22),

5. 11730836 - Synergistic cancer treatment (2023-08-22),

6. 11454861 - Hydrogels with biodegradable crosslinking (2022-09-27),

7. 11181803 - Hydrogels with biodegradable crosslinking (2021-11-23),

8. 11179470 - Hydrogels with biodegradable crosslinking (2021-11-23),

9. 10967925 - Mountable cleat apparatus (2021-04-06),

10. 10413594 - Conjugates of somatostatin analogues (2019-09-17),

11. 10398779 - Hydrogels with biodegradable crosslinking (2019-09-03),

12. 10342792 - Slow-release conjugates of SN-38 (2019-07-09),

13. 10086049 - Conjugates of somatostatin analogues (2018-10-02),

14. 10016411 - Slow-release conjugates of SN-38 (2018-07-10),

15. 9649385 - Hydrogels with biodegradable crosslinking (2017-05-16),

Prolynx LLC is a technology company based in San Francisco, specializing in advanced solutions for the life sciences sector. The organization focuses on developing innovative software and systems that enhance research and operational efficiencies in pharmaceutical and biotechnology industries. Prolynx is dedicated to improving data management and analysis, facilitating better decision-making processes in drug development and clinical trials. Its expertise lies in integrating cutting-edge technology with scientific research to drive advancements in healthcare.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

20 Patents

#240 in San Francisco, CA

#3,933 in California

#16,382 in US

#31,233 in the World

San Francisco, CA, United States of America

Prolynx LLC

Forward Citations = 140

12 inventors:

Gary W Ashley (16 out of 56 patents)

Daniel V Santi (15 out of 62 patents)

Jeffrey C Henise (5 out of 5 patents)

4. Eric L Schneider (5 out of 6 patents)

5. Brian R Hearn (4 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…